ACL — Australian Clinical Labs Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedSmall CapSuper Stock

Annual balance sheet for Australian Clinical Labs, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	27.5	20.6	26.8	22.1	25.7
Net Total Accounts Receivable
Net Total Receivables	91.1	75	81.4	72.8	67.4
Total Inventory
Prepaid Expenses
Total Current Assets	143	116	134	120	113
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	310	288	282	270	294
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	628	579	593	575	593
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	225	188	208	216	210
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	396	406	416	403	443
Common Stock
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	232	172	178	171	150
Total Liabilities & Shareholders' Equity	628	579	593	575	593
Total Common Shares Outstanding